APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liposome Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Liposome Service Market Outlook and Growth Opportunities 2026

5 March 2026207 pages

Choose your research edition.

Industry ResearchLiposome Service Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Liposome Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Liposome Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liposome Service Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Liposome Service Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Liposome Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Liposome Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Liposome Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liposome Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Liposome Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Liposome Service market include Acuitas Therapeutics, CD Bioparticles, Corden Pharma, Creative Biolabs, Creative Biostruct, Encapsula NanoSciences, Evonik, Exelead and FormuMax Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Liposome Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Liposome Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Liposome Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Liposome Service market.

Liposome Service Segment by Company

Acuitas Therapeutics

CD Bioparticles

Corden Pharma

Creative Biolabs

Creative Biostruct

Encapsula NanoSciences

Evonik

Exelead

FormuMax Scientific

FUJIFILM Pharmaceuticals USA

GMPriority Pharma

Lipoid

LIPOSOMA

Merck KGaA

Nippon Fine Chemical

PlantaCorp

Polymun

Liposome Service Segment by Type

Liposome Development Services

Liposome Customization Service

Liposome Encapsulation Services

Others

Liposome Service Segment by Application

Pharmaceutical

Life Sciences

Cosmetics and Skin Care Industrial

Others

Liposome Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Liposome Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Liposome Service key companies, revenue, market share, and recent developments.

3. To split the Liposome Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Liposome Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Liposome Service significant trends, drivers, influence factors in global and regions.

6. To analyze Liposome Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liposome Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Liposome Service industry.

Chapter 3: Detailed analysis of Liposome Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Liposome Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Liposome Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Liposome Service Industry Trends Table 2. Liposome Service Industry Drivers Table 3. Liposome Service Industry Opportunities and Challenges Table 4. Liposome Service Industry Restraints Table 5. Global Liposome Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Liposome Service Revenue Share by Company (2021-2026) Table 7. Global Liposome Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Liposome Service Key Company Manufacturing Base & Headquarters Table 9. Global Liposome Service Company, Product Type & Application Table 10. Global Liposome Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Liposome Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Liposome Development Services Table 15. Significant Companies of Liposome Customization Service Table 16. Significant Companies of Liposome Encapsulation Services Table 17. Significant Companies of Others Table 18. Global Liposome Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Liposome Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Liposome Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Liposome Service Sales Value Share by Type (2021-2026) Table 22. Global Liposome Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Table 24. Significant Companies of Life Sciences Table 25. Significant Companies of Cosmetics and Skin Care Industrial Table 26. Significant Companies of Others Table 27. Global Liposome Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Liposome Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Liposome Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Liposome Service Sales Value Share by Application (2021-2026) Table 31. Global Liposome Service Sales Value Share by Application (2027-2032) Table 32. Global Liposome Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Liposome Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Liposome Service Sales Value Share by Region (2021-2026) Table 35. Global Liposome Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Liposome Service Sales Value Share by Region (2027-2032) Table 37. Global Liposome Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Liposome Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Liposome Service Sales Value Market Share by Country (2021-2026) Table 40. Global Liposome Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Liposome Service Sales Value Market Share by Country (2027-2032) Table 42. Acuitas Therapeutics Company Information Table 43. Acuitas Therapeutics Business Overview Table 44. Acuitas Therapeutics Liposome Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Acuitas Therapeutics Liposome Service Product Portfolio Table 46. Acuitas Therapeutics Recent Development Table 47. CD Bioparticles Company Information Table 48. CD Bioparticles Business Overview Table 49. CD Bioparticles Liposome Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. CD Bioparticles Liposome Service Product Portfolio Table 51. CD Bioparticles Recent Development Table 52. Corden Pharma Company Information Table 53. Corden Pharma Business Overview Table 54. Corden Pharma Liposome Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Corden Pharma Liposome Service Product Portfolio Table 56. Corden Pharma Recent Development Table 57. Creative Biolabs Company Information Table 58. Creative Biolabs Business Overview Table 59. Creative Biolabs Liposome Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Creative Biolabs Liposome Service Product Portfolio Table 61. Creative Biolabs Recent Development Table 62. Creative Biostruct Company Information Table 63. Creative Biostruct Business Overview Table 64. Creative Biostruct Liposome Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Creative Biostruct Liposome Service Product Portfolio Table 66. Creative Biostruct Recent Development Table 67. Encapsula NanoSciences Company Information Table 68. Encapsula NanoSciences Business Overview Table 69. Encapsula NanoSciences Liposome Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Encapsula NanoSciences Liposome Service Product Portfolio Table 71. Encapsula NanoSciences Recent Development Table 72. Evonik Company Information Table 73. Evonik Business Overview Table 74. Evonik Liposome Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Evonik Liposome Service Product Portfolio Table 76. Evonik Recent Development Table 77. Exelead Company Information Table 78. Exelead Business Overview Table 79. Exelead Liposome Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Exelead Liposome Service Product Portfolio Table 81. Exelead Recent Development Table 82. FormuMax Scientific Company Information Table 83. FormuMax Scientific Business Overview Table 84. FormuMax Scientific Liposome Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. FormuMax Scientific Liposome Service Product Portfolio Table 86. FormuMax Scientific Recent Development Table 87. FUJIFILM Pharmaceuticals USA Company Information Table 88. FUJIFILM Pharmaceuticals USA Business Overview Table 89. FUJIFILM Pharmaceuticals USA Liposome Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. FUJIFILM Pharmaceuticals USA Liposome Service Product Portfolio Table 91. FUJIFILM Pharmaceuticals USA Recent Development Table 92. GMPriority Pharma Company Information Table 93. GMPriority Pharma Business Overview Table 94. GMPriority Pharma Liposome Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. GMPriority Pharma Liposome Service Product Portfolio Table 96. GMPriority Pharma Recent Development Table 97. Lipoid Company Information Table 98. Lipoid Business Overview Table 99. Lipoid Liposome Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Lipoid Liposome Service Product Portfolio Table 101. Lipoid Recent Development Table 102. LIPOSOMA Company Information Table 103. LIPOSOMA Business Overview Table 104. LIPOSOMA Liposome Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. LIPOSOMA Liposome Service Product Portfolio Table 106. LIPOSOMA Recent Development Table 107. Merck KGaA Company Information Table 108. Merck KGaA Business Overview Table 109. Merck KGaA Liposome Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Merck KGaA Liposome Service Product Portfolio Table 111. Merck KGaA Recent Development Table 112. Nippon Fine Chemical Company Information Table 113. Nippon Fine Chemical Business Overview Table 114. Nippon Fine Chemical Liposome Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Nippon Fine Chemical Liposome Service Product Portfolio Table 116. Nippon Fine Chemical Recent Development Table 117. PlantaCorp Company Information Table 118. PlantaCorp Business Overview Table 119. PlantaCorp Liposome Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. PlantaCorp Liposome Service Product Portfolio Table 121. PlantaCorp Recent Development Table 122. Polymun Company Information Table 123. Polymun Business Overview Table 124. Polymun Liposome Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Polymun Liposome Service Product Portfolio Table 126. Polymun Recent Development Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Liposome Service Product Image Figure 2. Global Liposome Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liposome Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Liposome Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Liposome Development Services Image Figure 8. Liposome Customization Service Image Figure 9. Liposome Encapsulation Services Image Figure 10. Others Image Figure 11. Global Liposome Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Liposome Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Liposome Service Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Image Figure 15. Life Sciences Image Figure 16. Cosmetics and Skin Care Industrial Image Figure 17. Others Image Figure 18. Global Liposome Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Liposome Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Liposome Service Sales Value Share by Application (2021-2032) Figure 21. Global Liposome Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Liposome Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Liposome Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America Liposome Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Liposome Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Liposome Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Liposome Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Liposome Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Liposome Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America Liposome Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Liposome Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Liposome Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Liposome Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Liposome Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Liposome Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Liposome Development Services
  • Liposome Customization Service
  • Liposome Encapsulation Services
  • Others
Applications
  • Pharmaceutical
  • Life Sciences
  • Cosmetics and Skin Care Industrial
  • Others
Companies covered
  • Acuitas Therapeutics
  • CD Bioparticles
  • Corden Pharma
  • Creative Biolabs
  • Creative Biostruct
  • Encapsula NanoSciences
  • Evonik
  • Exelead
  • FormuMax Scientific
  • FUJIFILM Pharmaceuticals USA
  • GMPriority Pharma
  • Lipoid
  • LIPOSOMA
  • Merck KGaA
  • Nippon Fine Chemical
  • PlantaCorp
  • Polymun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Liposome Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Liposome Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Liposome Service Market Dynamics
  1. 2.1 Liposome Service Industry Trends
  2. 2.2 Liposome Service Industry Drivers
  3. 2.3 Liposome Service Industry Opportunities and Challenges
  4. 2.4 Liposome Service Industry Restraints
3 Liposome Service Market by Company
  1. 3.1 Global Liposome Service Company Revenue Ranking in 2025
  2. 3.2 Global Liposome Service Revenue by Company (2021-2026)
  3. 3.3 Global Liposome Service Company Ranking (2024-2026)
  4. 3.4 Global Liposome Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Liposome Service Company Product Type and Application
  6. 3.6 Global Liposome Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Liposome Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Liposome Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Liposome Service Market by Type
  1. 4.1 Liposome Service Type Introduction
  2. 4.1.1 Liposome Development Services
  3. 4.1.2 Liposome Customization Service
  4. 4.1.3 Liposome Encapsulation Services
  5. 4.1.4 Others
  6. 4.2 Global Liposome Service Sales Value by Type
  7. 4.2.1 Global Liposome Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Liposome Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Liposome Service Sales Value Share by Type (2021-2032)
5 Liposome Service Market by Application
  1. 5.1 Liposome Service Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Life Sciences
  4. 5.1.3 Cosmetics and Skin Care Industrial
  5. 5.1.4 Others
  6. 5.2 Global Liposome Service Sales Value by Application
  7. 5.2.1 Global Liposome Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Liposome Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Liposome Service Sales Value Share by Application (2021-2032)
6 Liposome Service Regional Value Analysis
  1. 6.1 Global Liposome Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Liposome Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Liposome Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Liposome Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Liposome Service Sales Value (2021-2032)
  7. 6.3.2 North America Liposome Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Liposome Service Sales Value (2021-2032)
  10. 6.4.2 Europe Liposome Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Liposome Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Liposome Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Liposome Service Sales Value (2021-2032)
  16. 6.6.2 South America Liposome Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Liposome Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Liposome Service Sales Value Share by Country, 2025 VS 2032
7 Liposome Service Country-level Value Analysis
  1. 7.1 Global Liposome Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Liposome Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Liposome Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Liposome Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Liposome Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Liposome Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Liposome Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Liposome Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Liposome Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Liposome Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Liposome Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Liposome Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Liposome Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Liposome Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Liposome Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Liposome Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Liposome Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Liposome Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Liposome Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Liposome Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Liposome Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Liposome Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Liposome Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Liposome Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Liposome Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Liposome Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Liposome Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Liposome Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Liposome Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Liposome Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Liposome Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Liposome Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Liposome Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Liposome Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Liposome Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Liposome Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Liposome Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Liposome Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Liposome Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Liposome Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Liposome Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Liposome Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Liposome Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Liposome Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Liposome Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Liposome Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Liposome Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Liposome Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Liposome Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Liposome Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Liposome Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Liposome Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Liposome Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Liposome Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Liposome Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Liposome Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Liposome Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Liposome Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Liposome Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Liposome Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Liposome Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Liposome Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Liposome Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Liposome Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Liposome Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Liposome Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Liposome Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Liposome Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Liposome Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Liposome Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Liposome Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Liposome Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Liposome Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Liposome Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Liposome Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Liposome Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Liposome Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Liposome Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Liposome Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Liposome Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Liposome Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Liposome Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Liposome Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Liposome Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Liposome Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Liposome Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Liposome Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Liposome Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Acuitas Therapeutics
  2. 8.1.1 Acuitas Therapeutics Company Information
  3. 8.1.2 Acuitas Therapeutics Business Overview
  4. 8.1.3 Acuitas Therapeutics Liposome Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Acuitas Therapeutics Liposome Service Product Portfolio
  6. 8.1.5 Acuitas Therapeutics Recent Developments
  7. 8.2 CD Bioparticles
  8. 8.2.1 CD Bioparticles Company Information
  9. 8.2.2 CD Bioparticles Business Overview
  10. 8.2.3 CD Bioparticles Liposome Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CD Bioparticles Liposome Service Product Portfolio
  12. 8.2.5 CD Bioparticles Recent Developments
  13. 8.3 Corden Pharma
  14. 8.3.1 Corden Pharma Company Information
  15. 8.3.2 Corden Pharma Business Overview
  16. 8.3.3 Corden Pharma Liposome Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Corden Pharma Liposome Service Product Portfolio
  18. 8.3.5 Corden Pharma Recent Developments
  19. 8.4 Creative Biolabs
  20. 8.4.1 Creative Biolabs Company Information
  21. 8.4.2 Creative Biolabs Business Overview
  22. 8.4.3 Creative Biolabs Liposome Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Creative Biolabs Liposome Service Product Portfolio
  24. 8.4.5 Creative Biolabs Recent Developments
  25. 8.5 Creative Biostruct
  26. 8.5.1 Creative Biostruct Company Information
  27. 8.5.2 Creative Biostruct Business Overview
  28. 8.5.3 Creative Biostruct Liposome Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Creative Biostruct Liposome Service Product Portfolio
  30. 8.5.5 Creative Biostruct Recent Developments
  31. 8.6 Encapsula NanoSciences
  32. 8.6.1 Encapsula NanoSciences Company Information
  33. 8.6.2 Encapsula NanoSciences Business Overview
  34. 8.6.3 Encapsula NanoSciences Liposome Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Encapsula NanoSciences Liposome Service Product Portfolio
  36. 8.6.5 Encapsula NanoSciences Recent Developments
  37. 8.7 Evonik
  38. 8.7.1 Evonik Company Information
  39. 8.7.2 Evonik Business Overview
  40. 8.7.3 Evonik Liposome Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Evonik Liposome Service Product Portfolio
  42. 8.7.5 Evonik Recent Developments
  43. 8.8 Exelead
  44. 8.8.1 Exelead Company Information
  45. 8.8.2 Exelead Business Overview
  46. 8.8.3 Exelead Liposome Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Exelead Liposome Service Product Portfolio
  48. 8.8.5 Exelead Recent Developments
  49. 8.9 FormuMax Scientific
  50. 8.9.1 FormuMax Scientific Company Information
  51. 8.9.2 FormuMax Scientific Business Overview
  52. 8.9.3 FormuMax Scientific Liposome Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 FormuMax Scientific Liposome Service Product Portfolio
  54. 8.9.5 FormuMax Scientific Recent Developments
  55. 8.10 FUJIFILM Pharmaceuticals USA
  56. 8.10.1 FUJIFILM Pharmaceuticals USA Company Information
  57. 8.10.2 FUJIFILM Pharmaceuticals USA Business Overview
  58. 8.10.3 FUJIFILM Pharmaceuticals USA Liposome Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 FUJIFILM Pharmaceuticals USA Liposome Service Product Portfolio
  60. 8.10.5 FUJIFILM Pharmaceuticals USA Recent Developments
  61. 8.11 GMPriority Pharma
  62. 8.11.1 GMPriority Pharma Company Information
  63. 8.11.2 GMPriority Pharma Business Overview
  64. 8.11.3 GMPriority Pharma Liposome Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GMPriority Pharma Liposome Service Product Portfolio
  66. 8.11.5 GMPriority Pharma Recent Developments
  67. 8.12 Lipoid
  68. 8.12.1 Lipoid Company Information
  69. 8.12.2 Lipoid Business Overview
  70. 8.12.3 Lipoid Liposome Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lipoid Liposome Service Product Portfolio
  72. 8.12.5 Lipoid Recent Developments
  73. 8.13 LIPOSOMA
  74. 8.13.1 LIPOSOMA Company Information
  75. 8.13.2 LIPOSOMA Business Overview
  76. 8.13.3 LIPOSOMA Liposome Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 LIPOSOMA Liposome Service Product Portfolio
  78. 8.13.5 LIPOSOMA Recent Developments
  79. 8.14 Merck KGaA
  80. 8.14.1 Merck KGaA Company Information
  81. 8.14.2 Merck KGaA Business Overview
  82. 8.14.3 Merck KGaA Liposome Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Merck KGaA Liposome Service Product Portfolio
  84. 8.14.5 Merck KGaA Recent Developments
  85. 8.15 Nippon Fine Chemical
  86. 8.15.1 Nippon Fine Chemical Company Information
  87. 8.15.2 Nippon Fine Chemical Business Overview
  88. 8.15.3 Nippon Fine Chemical Liposome Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Nippon Fine Chemical Liposome Service Product Portfolio
  90. 8.15.5 Nippon Fine Chemical Recent Developments
  91. 8.16 PlantaCorp
  92. 8.16.1 PlantaCorp Company Information
  93. 8.16.2 PlantaCorp Business Overview
  94. 8.16.3 PlantaCorp Liposome Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 PlantaCorp Liposome Service Product Portfolio
  96. 8.16.5 PlantaCorp Recent Developments
  97. 8.17 Polymun
  98. 8.17.1 Polymun Company Information
  99. 8.17.2 Polymun Business Overview
  100. 8.17.3 Polymun Liposome Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Polymun Liposome Service Product Portfolio
  102. 8.17.5 Polymun Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst